No Data
No Data
Express News | Realcan Pharmaceutical Group: intends to repurchase shares of 0.1 billion yuan to -0.2 billion yuan.
Ruikang Pharmaceutical: Report for the third quarter of 2024
Express News | Realcan Pharmaceutical Group signed a cooperation project with Yang Baofeng, a pharmacologist and academician of the Chinese Academy of Engineering.
Ruikang Pharmaceutical: 2024 Semi-Annual Report Summary
Ruikang Pharmaceutical: 2024 Semi-Annual Report
Realcan Pharmaceutical Group (002589.SZ) released its half-yearly performance, with a net income of 31.03 million yuan, a year-on-year growth of 1.17%.
Realcan Pharmaceutical Group (002589.SZ) disclosed its 2024 interim report, with the company achieving a revenue of 40.3...
No Data
No Data